Communicating about potential drug harms: safety implications for patients.
Ritter
J M
JM
D003142:Communication; D003257:Consumer Product Safety / Q000592:standards*; D030881:Disclosure / Q000592:standards*; D011307:Drug Prescriptions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D010353:Patient Education as Topic
Br J Clin Pharmacol. 2008 Mar;65(3):440-1
17922884
Br J Clin Pharmacol. 2009 Jun;67(6):641-5
19594531
Br J Clin Pharmacol. 2009 Jun;67(6):605-13
19594527
Br J Clin Pharmacol. 2009 Jun;67(6):614-20
19594528
Br J Clin Pharmacol. 2009 Aug;68(2):269-70
19694748
Br J Clin Pharmacol. 2009 Jun;67(6):646-50
19594532
Br J Clin Pharmacol. 2009 Jun;67(6):599-604
19594526
Br J Clin Pharmacol. 2009 Jun;67(6):687-90
19594539
Br J Clin Pharmacol. 2009 Jun;67(6):624-8
19594530
Br J Clin Pharmacol. 2009 Jun;67(6):592-8
19594525
Br J Clin Pharmacol. 2009 Aug;68(2):271-3
19694749
Br J Clin Pharmacol. 2009 Aug;68(2):194-200
19694738
Br J Clin Pharmacol. 2009 Jun;67(6):671-5
19594536
Br J Clin Pharmacol. 2009 Jun;67(6):651-5
19594533
Br J Clin Pharmacol. 2009 Aug;68(2):260-8
19694747
Br J Clin Pharmacol. 2009 Jun;67(6):676-80
19594537
Br J Clin Pharmacol. 2009 Jun;67(6):681-6
19594538
Br J Clin Pharmacol. 2009 Aug;68(2):201-6
19694739
Br J Clin Pharmacol. 2009 Aug;68(2):226-37
19694743
Br J Clin Pharmacol. 2009 Jun;67(6):662-70
19594535
Br J Clin Pharmacol. 2009 Jun;67(6):621-3
19594529
Br J Clin Pharmacol. 2009 Jun;67(6):656-61
19594534
Br J Clin Pharmacol. 2009 Aug;68(2):187-93
19694737
Br J Clin Pharmacol. 2009 Jun;67(6):629-40
19094162